Stay updated on Recombinant Protein Vaccine Clinical Trial
Sign up to get notified when there's something new on the Recombinant Protein Vaccine Clinical Trial page.

Latest updates to the Recombinant Protein Vaccine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew revision v3.6.6 has been published for the study page, replacing the previous v3.6.5. This reflects an editorial update to the study record rather than changes to trial data or outcomes.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded page revision tag Revision: v3.6.5; removed items including VAT00002 Plain language Results Summary, the sponsor line 'Sanofi (Sanofi Pasteur, a Sanofi Company)', the 'Helpful Links Provided by' label, and the older 'Revision: v3.6.4'.SummaryDifference0.1%

- Check56 days agoChange DetectedA new software revision label Revision: v3.6.4 was added while Revision: v3.6.3 was removed, indicating an updated release note or footer/version indicator on the site.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page revision tag was updated to v3.6.3, indicating a minor update to the page infrastructure. This reflects an incremental change rather than new study information or content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a small site update and does not alter study details or results.SummaryDifference0.0%

- Check99 days agoChange DetectedNew guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) to aid user navigation. The page shows recruitment has ended ('No longer looking for participants') and the revision is updated to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Recombinant Protein Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Protein Vaccine Clinical Trial page.